Press Release - SUTUREGARD® Medical, Inc is Presenting at Arab Health

SUTUREGARD® Medical, Inc. Blog

 
16Jan

Press Release - SUTUREGARD® Medical, Inc is Presenting at Arab Health

Press Release | | Return|

SUTUREGARD® Medical, Inc is excited to announce that CEO Dan Ladizinsky, MD, will be presenting SUTUREGARD® Medical at Arab Health. Arab Health, which runs January 27 to 30 in Dubai, brings in over 4,250 companies to showcase all the latest innovations in healthcare.

“We are honored to be supported by Business Oregon and out strategic partner, Demetch Inc of Miami Lakes, Florida to attend Arab Health”, says Ladizinsky, “It will be our first time there and we will be able to build on our positive market response at Medica 2019 in Germany”. Arab Health will allow SUTUREGARD® Medical, Inc to meet new customers, showcase the SUTUREGARD® ISR Device, introduce their second product, the HEMIGARD Adhesive Retention Suture Device, and further develop relationships.

For 45 years Arab Health has been at the forefront of innovations in healthcare. With over 55,000 attendees and 159 countries represented at the show, Arab Health continues to host the largest collection of healthcare product manufacturers and service providers.

SUTUREGARD® Medical, Inc is proud to be a representative of the United States and showcase its medical products to “the international market, focusing on the Middle East and North Africa (MENA) region”, says Ladizinsky. SUTUREGARD® Medical and Ladizinsky can be found demonstrating at booth #Z6-G01 in the Dubai World Trade Centre.

Based in Portland, Oregon, SUTUREGARD® Medical, Inc is a private firm that provides surgical equipment for surgeons to provide quality high-tension wound closure on patients around the world. With a wide variety of devices available to surgeons, SUTUREGARD® Medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients overall. The firm is funded by the Oregon State University Venture Development Fund, as well as through private allocation of funds.

Related

Press Release - Operation Smile

The official collaboration between Operation Smile & SUTUREGARD® Medical Inc. Operation Smile is the...

Read More >

What is Moh's Surgery?

Mohs surgery relies on processing tissue. The tumor is removed but then it is studied & laid down to...

Read More >

Are Scalp Repairs Slowing You Down?

Skip the scalp flap or graft with the SUTUREGARD® Rapid Interaoperative Tissue Expansion (RITE) Devi...

Read More >

Press Release - SUTUREGARD® Medical and Federated Healthcare Supply Sign Non-Exclusive Distribution Deal

SUTUREGARD® Medical has formed a non-exclusive distribution partnership with Federated Healthcare Su...

Read More >

Why We Use GluSeal® With Our HEMIGARD™- Assisted Skin Closures

Our research has demonstrated that the middle suture in an elliptical wound is under approximately s...

Read More >

Press Release - SUTUREGARD® Presenting at the American Society for Mohs Surgery

SUTUREGARD® Medical will be presenting at the American Society for Mohs Surgery (ASMS) Closure Cours...

Read More >

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now